Dow Up 0.66% Nasdaq Up 0.88%

Impax Laboratories Inc. (IPXL)

-NasdaqGS
33.13 Down 0.22(0.66%) 4:00PM EDT
|After Hours : 33.13 0.00 (0.00%) 4:09PM EDT - Nasdaq Real Time Price
Prev Close:33.35
Open:33.53
Bid:33.12 x 800
Ask:33.13 x 1000
1y Target Est:40.77
Beta:1.23423
Next Earnings Date:10-May-16IPXL Earnings announcement
Day's Range:32.80 - 33.76
52wk Range:29.66 - 51.42
Volume:620,293
Avg Vol (3m):735,180
Market Cap:2.45B
P/E (ttm):61.35
EPS (ttm):0.54
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IPXL

Comparison

Symbol% ChgMkt Cap
IPXLDown 0.66%2.45B
MYLUp 2.40%20.96B

Key Statistics

Forward P/E (1 yr):14.40
P/S (ttm):2.73
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :1.80
Quarterly EPS Est (Mar-16) :0.39
Mean Recommendation*:2.6
PEG Ratio (5 yr expected):0.72

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Impax Generics and Impax Specialty Pharma. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback